IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Kura Oncology
Symbol: KURA
Price: Last trade $16.00
Description: Their common stock is quoted on the OTCQB under the symbol “KURO”
Trade Date: 11/5
Shares: 3.75 million
Underwriter(s) Citigroup, Leerink Partners
Co Manager(s) JMP Securities, Oppenheimer
Rating=Subscription Needed
Company: New York Community Bancorp
Symbol: NYCB
Price: Last trade $19.16
Trade Date: 10/30
Shares: 33.9 million
Underwriter(s) Goldman Sachs, Credit Suisse
Rating=Subscription Needed
Company: MDC Partners Inc.-BLOCK
Symbol: MDCA
Price: Last trade $20.96
Trade Date: 10/30
Shares: 1 million
Underwriter(s) Jefferies
Rating=Subscription Needed